Two Generic Versions of Imatinib Launched -- but Will Prices Drop? Two Generic Versions of Imatinib Launched -- but Will Prices Drop?

Two new generic versions have now been launched and will be vying with Novartis and Sun Pharmaceuticals for market share, but the question remains: will it even affect the high price?Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news